scorecardresearch
Add as a preferred source on Google
Wednesday, January 14, 2026
TopicDGCI

Topic: DGCI

Months after import duty waiver, GST slashed on same 3 anti-cancer drugs. Why this is little relief

Centre moves to reduce costs of trastuzumab deruxtecan, osimertinib & durvalumab, all 3 by British-Swedish pharma giant AstraZeneca. Doctors seek exemptions for more such drugs. 

Tough pill to swallow for e-pharmacies as govt’s draft bill proposes curbs on online sale of drugs

Likely to be presented to Cabinet before being tabled in Parliament, latest version of draft bill aims to regulate, restrict or ban online sale of prescription drugs.

On Camera

India has 7.4% growth, but faltering tax revenue could have implications in coming fiscal year

In the first eight months of the current fiscal year, New Delhi’s net tax intake didn’t even hit the halfway mark of what it expects to collect by March 31.

Grounded no more: Andhra govt revives no-frills Dagadarthi airport near Nellore to boost south coast link

As Visakhapatnam readies a mega airport, the Andhra Pradesh government has revived its shelved Dagadarthi project, aiming to boost cargo and connectivity on the south coast.

Army chief lambasts Chinese infra push in Shaksgam Valley. ‘We consider it illegal action’

Speaking at annual press conference, Army chief reiterated that India does not recognise 1963 Sino-Pakistan border pact under which Pakistan illegally ceded Shaksgam Valley to China.

Thank you Donald Trump, again. India now has reason to shed fear of trade deals and risky reform

UK, EFTA already in the bag and EU on the way, many members of RCEP except China signed up, and even restrictions on China being lifted, India has changed its mind on trade.